These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25917481)

  • 1. A Semiconductor Chip-Based Next Generation Sequencing Procedure for the Main Pulmonary Hypertension Genes.
    Gómez J; Reguero JR; Alvarez C; Junquera MR; Arango A; Morís C; Coto E
    Lung; 2015 Aug; 193(4):571-4. PubMed ID: 25917481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic counselling in a national referral centre for pulmonary hypertension.
    Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
    Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in BMPR2 are not present in patients with pulmonary hypertension associated with congenital diaphragmatic hernia.
    Chiu JS; Ma L; Wynn J; Krishnan U; Rosenzweig EB; Aspelund G; Arkovitz M; Warner BW; Lim FY; Mychaliska GB; Azarow K; Cusick RA; Chung DH; Chung WK
    J Pediatr Surg; 2017 Nov; 52(11):1747-1750. PubMed ID: 28162765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
    Best DH; Sumner KL; Smith BP; Damjanovich-Colmenares K; Nakayama I; Brown LM; Ha Y; Paul E; Morris A; Jama MA; Dodson MW; Bayrak-Toydemir P; Elliott CG
    Chest; 2017 Apr; 151(4):821-828. PubMed ID: 27884767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
    Eichstaedt CA; Song J; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
    Respir Res; 2016 Nov; 17(1):141. PubMed ID: 27809840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of pulmonary arterial hypertension.
    Austin ED; Loyd JE
    Circ Res; 2014 Jun; 115(1):189-202. PubMed ID: 24951767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Characterization of
    Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
    Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritable pulmonary hypertension: from bench to bedside.
    Girerd B; Weatherald J; Montani D; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28877973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.
    Haarman MG; Kerstjens-Frederikse WS; Vissia-Kazemier TR; Breeman KTN; Timens W; Vos YJ; Roofthooft MTR; Hillege HL; Berger RMF
    J Pediatr; 2020 Oct; 225():65-73.e5. PubMed ID: 32502478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension.
    Navas P; Tenorio J; Quezada CA; Barrios E; Gordo G; Arias P; López Meseguer M; Santos-Lozano A; Palomino Doza J; Lapunzina P; Escribano Subías P
    Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1011-1019. PubMed ID: 27453251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heritable forms of pulmonary arterial hypertension.
    Austin ED; Loyd JE
    Semin Respir Crit Care Med; 2013 Oct; 34(5):568-80. PubMed ID: 24037626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Pattathu J; Gorenflo M; Hilgendorff A; Koskenvuo JW; Apitz C; Hansmann G; Alastalo TP
    Heart; 2016 May; 102 Suppl 2():ii36-41. PubMed ID: 27053696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.
    Zeng Q; Yang H; Liu B; Ma Y; Liu Z; Chen Q; Li W; Luo Q; Zhao Z; Zhou Z; Xiong C
    BMC Pulm Med; 2020 May; 20(1):150. PubMed ID: 32471403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNK3: new gene target for pulmonary hypertension?
    Girerd B; Perros F; Antigny F; Humbert M; Montani D
    Expert Rev Respir Med; 2014 Aug; 8(4):385-7. PubMed ID: 24742047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension.
    Higasa K; Ogawa A; Terao C; Shimizu M; Kosugi S; Yamada R; Date H; Matsubara H; Matsuda F
    BMC Pulm Med; 2017 Apr; 17(1):57. PubMed ID: 28388887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations.
    Morse J; Barst R; Horn E; Cuervo N; Deng Z; Knowles J
    J Rheumatol; 2002 Nov; 29(11):2379-81. PubMed ID: 12415595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genetic defects in pulmonary arterial hypertension by a new gene panel diagnostic tool.
    Song J; Eichstaedt CA; Viales RR; Benjamin N; Harutyunova S; Fischer C; Grünig E; Hinderhofer K
    Clin Sci (Lond); 2016 Nov; 130(22):2043-2052. PubMed ID: 27613157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension.
    Nasim MT; Ogo T; Ahmed M; Randall R; Chowdhury HM; Snape KM; Bradshaw TY; Southgate L; Lee GJ; Jackson I; Lord GM; Gibbs JS; Wilkins MR; Ohta-Ogo K; Nakamura K; Girerd B; Coulet F; Soubrier F; Humbert M; Morrell NW; Trembath RC; Machado RD
    Hum Mutat; 2011 Dec; 32(12):1385-9. PubMed ID: 21898662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel channelopathy in pulmonary arterial hypertension.
    Ma L; Roman-Campos D; Austin ED; Eyries M; Sampson KS; Soubrier F; Germain M; Trégouët DA; Borczuk A; Rosenzweig EB; Girerd B; Montani D; Humbert M; Loyd JE; Kass RS; Chung WK
    N Engl J Med; 2013 Jul; 369(4):351-361. PubMed ID: 23883380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.